Key points are not available for this paper at this time.
Design
Review
Authors
No takes yet. Share an insight, caveat, or question.
Endothelin-Ca2+ mechanisms warrant no practice change; leaves open targeted vascular trials.
Craig B. Neylon (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: